Highlights
AMEX: INO       Inovio Pharma
Last Price Today's Change   Day's Range   Trading Volume
8.69   -0.01 (0.11%)  8.53 - 9.06  3,742,000

Overview

 
Avg Volume (4 weeks):5,595,629
4 Weeks Range:6.98 - 10.33
4 Weeks Price Volatility (%):
51.04%
52 Weeks Range:5.81 - 33.79
52 Weeks Price Volatility (%):
10.29%
Average Price Target: 0.70
Price Target Upside/Downside: -7.99

Headlines



No recent Headlines for this stock.


Business Background

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), Ebola, Middle East Respiratory Syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, it has a pipeline of pre-clinical and clinical stage products that have generated in vivo immune responses.

  Be the first to like this.
 
selamba so good counter
05/08/2013 8:11 PM


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

4561  5199  840  247 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 SNDL 1.00+0.108 
 ENTX 6.50+2.01 
 CLOV 13.83+1.20 
 WISH 13.61+0.11 
 TRCH 4.92-2.08 
 ORPH 7.44+1.47 
 AMC 58.30+0.03 
 GSAT 1.77-0.09 
 F 15.42+0.51 
 ACST 0.596+0.056